<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Quantum Discovery Labs &#187; antiviral</title>
	<atom:link href="http://q-pharm.com/category/antiviral/feed/" rel="self" type="application/rss+xml" />
	<link>http://q-pharm.com</link>
	<description>The drug discovery company</description>
	<lastBuildDate>Fri, 03 Feb 2012 10:47:43 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
		<item>
		<title>New MA/p17 matrix protein inhibitors display broad antiviral activity against multiple subtypes of HIV-1</title>
		<link>http://q-pharm.com/2011/06/new-map17-matrix-protein-inhibitors-display-broad-antiviral-activity-against-multiple-subtypes-of-hiv-1/</link>
		<comments>http://q-pharm.com/2011/06/new-map17-matrix-protein-inhibitors-display-broad-antiviral-activity-against-multiple-subtypes-of-hiv-1/#comments</comments>
		<pubDate>Tue, 21 Jun 2011 11:28:21 +0000</pubDate>
		<dc:creator>Peter Fedichev, Quantum CTO</dc:creator>
				<category><![CDATA[antiviral]]></category>
		<category><![CDATA[drug design]]></category>
		<category><![CDATA[HIV]]></category>
		<category><![CDATA[matrix proteins]]></category>

		<guid isPermaLink="false">http://q-pharm.com/?p=390</guid>
		<description><![CDATA[A key issue in the development of novel HIV drugs is their ability to inhibit the replication of genetically diverse isolates, especially those isolates from the most globally prevalent subtypes, [...]


Related posts:<ol><li><a href='http://q-pharm.com/2011/04/influenza-matrix-m1-protein-inhibitors-show-promising-in-vivo-efficacy/' rel='bookmark' title='Influenza matrix M1 protein inhibitors show promising in-vivo efficacy'>Influenza matrix M1 protein inhibitors show promising in-vivo efficacy</a></li>
<li><a href='http://q-pharm.com/2011/12/map17-hiv-matrix-protein-is-a-promising-target-for-drug-discovery/' rel='bookmark' title='MA/p17 HIV matrix protein is a promising target for drug discovery'>MA/p17 HIV matrix protein is a promising target for drug discovery</a></li>
<li><a href='http://q-pharm.com/2008/09/from-biological-spectra-multiple-protein-binding-data-to-pharmacological-profiling/' rel='bookmark' title='From Biological Spectra (multiple protein binding data) to pharmacological profiling!'>From Biological Spectra (multiple protein binding data) to pharmacological profiling!</a></li>
<li><a href='http://q-pharm.com/2009/11/do-we-need-those-nm-inhibitors/' rel='bookmark' title='Do we need those nM-inhibitors?'>Do we need those nM-inhibitors?</a></li>
<li><a href='http://q-pharm.com/2010/01/drug-resistance-evolution-in-action/' rel='bookmark' title='Drug resistance: evolution in action'>Drug resistance: evolution in action</a></li>
</ol>

Related posts brought to you by <a href='http://yarpp.org'>Yet Another Related Posts Plugin</a>.]]></description>
		<wfw:commentRss>http://q-pharm.com/2011/06/new-map17-matrix-protein-inhibitors-display-broad-antiviral-activity-against-multiple-subtypes-of-hiv-1/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Beefing up the pipeline: new leads against influenza virus identified</title>
		<link>http://q-pharm.com/2010/09/beefing-up-the-pipeline-new-leads-against-influenza-virus-identified/</link>
		<comments>http://q-pharm.com/2010/09/beefing-up-the-pipeline-new-leads-against-influenza-virus-identified/#comments</comments>
		<pubDate>Mon, 20 Sep 2010 07:49:30 +0000</pubDate>
		<dc:creator>Peter Fedichev, Quantum CTO</dc:creator>
				<category><![CDATA[antiviral]]></category>
		<category><![CDATA[drug design]]></category>
		<category><![CDATA[flue]]></category>
		<category><![CDATA[influenza]]></category>
		<category><![CDATA[Quantum Software]]></category>

		<guid isPermaLink="false">http://q-pharm.com/?p=317</guid>
		<description><![CDATA[Quantum Free energy calculation software in combination with the docking tools and clustering tools to &#8220;zip&#8221; the amount of work required to screen the large libraries of the available chemical [...]


Related posts:<ol><li><a href='http://q-pharm.com/2011/04/influenza-matrix-m1-protein-inhibitors-show-promising-in-vivo-efficacy/' rel='bookmark' title='Influenza matrix M1 protein inhibitors show promising in-vivo efficacy'>Influenza matrix M1 protein inhibitors show promising in-vivo efficacy</a></li>
<li><a href='http://q-pharm.com/2011/08/structure-based-drug-design-of-a-new-chemical-class-of-small-molecules-active-against-influenza-a-nucleoprotein-in-vitro-and-in-vivo/' rel='bookmark' title='Structure-based drug design of a new chemical class of small molecules active against influenza A nucleoprotein in vitro and in vivo'>Structure-based drug design of a new chemical class of small molecules active against influenza A nucleoprotein in vitro and in vivo</a></li>
<li><a href='http://q-pharm.com/2010/07/new-inhibitors-of-reca-bacterial-sos-response-system-identified/' rel='bookmark' title='New inhibitors of RecA (bacterial SOS response system) identified.'>New inhibitors of RecA (bacterial SOS response system) identified.</a></li>
</ol>

Related posts brought to you by <a href='http://yarpp.org'>Yet Another Related Posts Plugin</a>.]]></description>
		<wfw:commentRss>http://q-pharm.com/2010/09/beefing-up-the-pipeline-new-leads-against-influenza-virus-identified/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Drug resistance: evolution in action</title>
		<link>http://q-pharm.com/2010/01/drug-resistance-evolution-in-action/</link>
		<comments>http://q-pharm.com/2010/01/drug-resistance-evolution-in-action/#comments</comments>
		<pubDate>Wed, 06 Jan 2010 08:40:08 +0000</pubDate>
		<dc:creator>Peter Fedichev, Quantum CTO</dc:creator>
				<category><![CDATA[antiviral]]></category>
		<category><![CDATA[flue]]></category>
		<category><![CDATA[Quantum Software]]></category>
		<category><![CDATA[selectivity]]></category>
		<category><![CDATA[anti-viral compounds]]></category>

		<guid isPermaLink="false">http://q-pharm.com/?p=176</guid>
		<description><![CDATA[Introduction of drugs puts an evolutionary pressure on viruses and makes the viral proteins evolve. On the other hand, the change in the protein structure should be compatible with the [...]


Related posts:<ol><li><a href='http://q-pharm.com/2011/12/map17-hiv-matrix-protein-is-a-promising-target-for-drug-discovery/' rel='bookmark' title='MA/p17 HIV matrix protein is a promising target for drug discovery'>MA/p17 HIV matrix protein is a promising target for drug discovery</a></li>
<li><a href='http://q-pharm.com/2007/09/quantum-and-albumin-binding-calculations-the-role-of-protein-flexibility/' rel='bookmark' title='QUANTUM and HSA binding calculations: the role of protein flexibility'>QUANTUM and HSA binding calculations: the role of protein flexibility</a></li>
<li><a href='http://q-pharm.com/2008/09/whats-an-ultimate-value-of-reversible-drug-binding-constant/' rel='bookmark' title='What&#8217;s an ultimate value of reversible drug binding constant?'>What&#8217;s an ultimate value of reversible drug binding constant?</a></li>
<li><a href='http://q-pharm.com/quantum-discovery-services/drug-design-drug-development-bioinformatics-and-preclinical-services/' rel='bookmark' title='Drug design, drug development, bioinformatics and preclinical services'>Drug design, drug development, bioinformatics and preclinical services</a></li>
<li><a href='http://q-pharm.com/2010/07/new-inhibitors-of-reca-bacterial-sos-response-system-identified/' rel='bookmark' title='New inhibitors of RecA (bacterial SOS response system) identified.'>New inhibitors of RecA (bacterial SOS response system) identified.</a></li>
</ol>

Related posts brought to you by <a href='http://yarpp.org'>Yet Another Related Posts Plugin</a>.]]></description>
		<wfw:commentRss>http://q-pharm.com/2010/01/drug-resistance-evolution-in-action/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Quantum collaborates with University of Pittsburgh on HIV drug discovery.</title>
		<link>http://q-pharm.com/2008/10/quantum-pharmaceuticals-collaborates-with-university-of-pittsburgh-on-hiv-drug-discovery/</link>
		<comments>http://q-pharm.com/2008/10/quantum-pharmaceuticals-collaborates-with-university-of-pittsburgh-on-hiv-drug-discovery/#comments</comments>
		<pubDate>Tue, 28 Oct 2008 14:09:00 +0000</pubDate>
		<dc:creator>businessdev</dc:creator>
				<category><![CDATA[antiviral]]></category>
		<category><![CDATA[collaboration]]></category>
		<category><![CDATA[HIV]]></category>

		<guid isPermaLink="false">http://q-pharm.com/?p=42</guid>
		<description><![CDATA[
Moscow, October, 20 2008
Quantum and University of Pittsburgh announced a drug discovery collaboration in HIV sphere. Under the terms of agreement Quantum gets access to the target data from University [...]


Related posts:<ol><li><a href='http://q-pharm.com/2006/10/hiv-1-integrase-drug-discovery-collaboration/' rel='bookmark' title='HIV-1 integrase drug discovery collaboration'>HIV-1 integrase drug discovery collaboration</a></li>
<li><a href='http://q-pharm.com/2008/09/quantum-pharmaceuticals-collaborates-with-fox-chase-cancer-center-on-discovery-of-new-small-molecules-inhibitors-in-cancer-area/' rel='bookmark' title='Quantum collaborates with Fox Chase Cancer Center on discovery of new small molecules inhibitors in cancer area.'>Quantum collaborates with Fox Chase Cancer Center on discovery of new small molecules inhibitors in cancer area.</a></li>
<li><a href='http://q-pharm.com/2008/05/quantum-pharmaceuticals-and-tibotec-pharmaceuticals-enter-antiviral-drug-discovery-collabortaion/' rel='bookmark' title='Quantum and Tibotec Pharmaceuticals enter antiviral drug discovery collabortaion.'>Quantum and Tibotec Pharmaceuticals enter antiviral drug discovery collabortaion.</a></li>
<li><a href='http://q-pharm.com/2006/06/quantum-pharmaceuticals-and-institute-of-pulmonology-entered-copd-drug-discovery-collaboration/' rel='bookmark' title='Quantum and Institute of Pulmonology entered COPD drug discovery collaboration.'>Quantum and Institute of Pulmonology entered COPD drug discovery collaboration.</a></li>
<li><a href='http://q-pharm.com/2008/06/quantum-pharmaceuticals-announce-collaboration-with-university-of-colorado-at-boulder/' rel='bookmark' title='Quantum announce collaboration with University of Colorado at Boulder'>Quantum announce collaboration with University of Colorado at Boulder</a></li>
</ol>

Related posts brought to you by <a href='http://yarpp.org'>Yet Another Related Posts Plugin</a>.]]></description>
		<wfw:commentRss>http://q-pharm.com/2008/10/quantum-pharmaceuticals-collaborates-with-university-of-pittsburgh-on-hiv-drug-discovery/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Quantum and Tibotec Pharmaceuticals enter antiviral drug discovery collabortaion.</title>
		<link>http://q-pharm.com/2008/05/quantum-pharmaceuticals-and-tibotec-pharmaceuticals-enter-antiviral-drug-discovery-collabortaion/</link>
		<comments>http://q-pharm.com/2008/05/quantum-pharmaceuticals-and-tibotec-pharmaceuticals-enter-antiviral-drug-discovery-collabortaion/#comments</comments>
		<pubDate>Sat, 24 May 2008 09:00:00 +0000</pubDate>
		<dc:creator>businessdev</dc:creator>
				<category><![CDATA[antiviral]]></category>
		<category><![CDATA[collaboration]]></category>

		<guid isPermaLink="false">http://q-pharm.com/?p=28</guid>
		<description><![CDATA[Quantum announces a drug discovery collaboration with Tibotec Pharmaceuticals (subsidiary of Johnson &#38; Johnson).
Under the terms of the agreement Quantum will provide Tibotec Pharmaceuticals with the family of anti-viral drug [...]


Related posts:<ol><li><a href='http://q-pharm.com/2006/10/hiv-1-integrase-drug-discovery-collaboration/' rel='bookmark' title='HIV-1 integrase drug discovery collaboration'>HIV-1 integrase drug discovery collaboration</a></li>
<li><a href='http://q-pharm.com/2006/06/quantum-pharmaceuticals-and-institute-of-pulmonology-entered-copd-drug-discovery-collaboration/' rel='bookmark' title='Quantum and Institute of Pulmonology entered COPD drug discovery collaboration.'>Quantum and Institute of Pulmonology entered COPD drug discovery collaboration.</a></li>
<li><a href='http://q-pharm.com/2008/03/quantum-pharmaceuticals-and-otechestvennye-lekarstva-ojsc-entered-drug-discovery-collaboration/' rel='bookmark' title='Quantum and Otechestvennye Lekarstva OJSC entered drug discovery collaboration.'>Quantum and Otechestvennye Lekarstva OJSC entered drug discovery collaboration.</a></li>
<li><a href='http://q-pharm.com/2008/09/quantum-pharmaceuticals-collaborates-with-fox-chase-cancer-center-on-discovery-of-new-small-molecules-inhibitors-in-cancer-area/' rel='bookmark' title='Quantum collaborates with Fox Chase Cancer Center on discovery of new small molecules inhibitors in cancer area.'>Quantum collaborates with Fox Chase Cancer Center on discovery of new small molecules inhibitors in cancer area.</a></li>
<li><a href='http://q-pharm.com/2008/10/quantum-pharmaceuticals-collaborates-with-university-of-pittsburgh-on-hiv-drug-discovery/' rel='bookmark' title='Quantum collaborates with University of Pittsburgh on HIV drug discovery.'>Quantum collaborates with University of Pittsburgh on HIV drug discovery.</a></li>
</ol>

Related posts brought to you by <a href='http://yarpp.org'>Yet Another Related Posts Plugin</a>.]]></description>
		<wfw:commentRss>http://q-pharm.com/2008/05/quantum-pharmaceuticals-and-tibotec-pharmaceuticals-enter-antiviral-drug-discovery-collabortaion/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

